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Abstract 
Background: The normal process of aging causes numerous physiological changes that affect 
pharmacodynamics and pharmacokinetics. Therefore, the geriatric population is more vulnerable 
to the effects of potentially inappropriate medication. The American Geriatric Society’s Beers 
Criteria identifies potentially inappropriate medication to be avoided for this population and can 
be implemented in efforts to avoid risks associated for this population. 
Aim and Methods: The purpose of this quality improvement project was to implement the Beers 
Criteria to identify potentially inappropriate medications among patients 65 years and older. The 
objectives were to increase the percentage of charts reviewed for inappropriate medications and 
to increase the use of alternative treatments based on Beers Criteria recommendations. 
Results: During the medication reconciliation process, the Beers Criteria was implemented to 
assess for inappropriate medications for eligible patients. A checklist was utilized to document 
the intervention process and the physician’s decision to continue or alter treatment. On a weekly 
basis, the student determined the percentage of charts reviewed and the percentage of altered 
treatment. Of the 112 geriatric patients included, 103 (91.3%) patients had their medications 
reviewed and 59 (57.2%) patients had at least one potentially inappropriate medication 
identified. However, only 7 (11.8%) patients had the medication altered.  
Implications for Practice: The implementation of the Beers Criteria will assist healthcare 
providers in identifying potentially inappropriate medications, preventing use of these 
medications, and utilizing alternative treatment to promote medication safety and optimize 
patient outcomes in geriatric patients.  
Keywords: Beers Criteria, geriatric, elderly, medication safety, polypharmacy, 
potentially inappropriate medication 
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Identification of Potentially Inappropriate Medication Utilizing the 
Beers Criteria Among Elderly Patients 
 The prescription of inappropriate medication (PIM) is the use of medicines and herbal 
supplements in which the risk of an adverse drug event (ADE) outweighs its benefit when there 
are safer and/or more effective alternative medication or treatment options available. PIM also 
includes the use of medications that may increase the likelihood of drug-drug interactions, drug-
disease interactions, misuse, overuse, and underuse of clinically indicated medications (Boland, 
Guignard, Dalleur, & Lang, 2016). Unfortunately, this is a common issue among the geriatric 
population 65 years and older due to the many factors that contribute to their vulnerability to 
PIMs. These contributing factors include age-related changes that alter pharmacokinetics and 
pharmodynamics; multiple chronic conditions (MCC); polypharmacy; physical and cognitive 
impairment; lack of adherence to complex medication regimens; and the lack of awareness and 
skills of healthcare providers regarding pharmacology in the geriatric population (Boland et al., 
2016).   
 The American Geriatric Society’s (AGS) Beers Criteria for Potentially Inappropriate 
Medication Use in Older Adults is one of the leading sources of evidence-based information 
regarding the safety of prescription medication for elderly patients. The Beers Criteria identifies 
medications and classes of medications that are considered “potentially inappropriate” for use in 
the elderly population (Health in Aging, 2015). Therefore, healthcare providers should avoid 
these listed medications that present a higher risk of ADEs and consider a safer alternative 
medication or non-drug remedy for patients 65 years and older. By utilizing this criterion, 
healthcare providers can help prevent ADEs and other drug-related complications in the elderly 
population. However, the lack of awareness and implementation of the Beers Criteria prevents 
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healthcare providers from identifying PIMs and considering other alternative treatment options. 
As a result, the use of PIMs continues to be an issue among the geriatric population 65 years and 
older. 
Statement of the Problem 
 The normal process of aging lends to numerous physiological changes; therefore, the 
effects of medication experienced by an older adult are unpredictable. Pharmacodynamics, or the 
study of the effects of drugs on the human body, is often difficult to predict and may result in an 
alteration in the desired effects of a drug because receptor sites may lose affinity or its decrease 
in responsiveness to medication occurring with age (Terrery & Nicoteri, 2016). Similarly, the 
aging process also alters pharmacokinetics, the study of the human body’s involvement and its 
effect on drug absorption, distribution, metabolism, and elimination (Terrery & Nicoteri, 2016). 
There are several physiological changes that occur in older adults that may affect 
pharmacokinetics including increased body fat, decreased body mass, decreased serum albumin, 
decreased liver size, slow cytochrome P450 reactions, inadequate renal function, and decreased 
cardiac output (Terrery & Nicoteri, 2016).  
 In addition to these physiological changes, the prevalence of MCC increases with age and 
is prevalent among the geriatric population (U.S. Department of Health and Human Services, 
2010). Therefore, certain chronic conditions or disease states such as chronic kidney disease 
(CKD) may also affect pharmacodynamics and pharmacokinetics. Management of these chronic 
conditions may require a complex medication regimen resulting in polypharmacy, a common 
phenomenon in the aged population that is associated with PIM use and ADEs (Zeenny, Wakim, 
& Kuyumjian, 2017). Due to the geriatric population’s increased risk and vulnerability to PIMs, 
the Beers Criteria was designed for the identification of PIMs and prevention of ADEs in this 
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population. The problem occurs when healthcare providers fail to utilize and implement the 
Beers Criteria into practice resulting in the continued use of PIMs for this vulnerable population.  
Background and Significance 
 The rapid aging and current increase in the number and proportion of the older adult 
population is an unprecedented event in United States’ history. It is predicted that the American 
geriatric population aged 65 or older will more than double, numbering approximately 89 million 
people by 2050 (Centers for Disease Control and Prevention [CDC], 2013; Ortman, Velkoff, & 
Hogan, 2014). Despite the public health strategies and advances in medical treatment that have 
increased the life expectancy of older adult by 30 years, the risk of developing a chronic disease 
increases as an individual ages (CDC, 2013). The root causes of these diseases are associated 
with unhealthy behaviors from an early age and the natural physiological changes that occur with 
the aging process (CDC, 2013). According to the CDC (2013), more than a quarter of all 
Americans or two out of every three older Americans have been diagnosed with MCC. The 
burden of MCC often results in a gradual decline in activities of daily living, diminished quality 
of life, and increased health care costs (CDC, 2013). It is estimated, that the geriatric population 
accounts for approximately 66% of the health care budget and 95% of all health care costs for 
older adults are used to treat MCC (CDC, 2013).  
 Although heart disease and cancer pose the greatest risk for the older adult, CKD is 
another chronic condition that the older adult is at risk for developing as one ages. CKD is 
defined as an abnormality in renal structure or function that results in a glomerular filtration rate 
(GFR) of less than 60 ml/min/1.73m2 for a duration of at least three months or longer (National 
Kidney Foundation, 2014). Common risk factors for developing CKD include hypertension, 
diabetes mellitus, hyperlipidemia, and elevated uric acid; therefore, adults with diabetes mellitus 
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and/or hypertension are at higher risk for developing CKD than those without these conditions 
(CDC, 2017). According to the CDC (2017), it is estimated that 30 million people or 15% of 
adults suffer from CKD. Specifically, in the United States, it is estimated that approximately 
661,000 individuals have been diagnosed with CKD (National Institute of Diabetes and 
Digestive and Kidney Diseases, 2016). Not only can CKD lead to other health complications, but 
also the lack of renal function results in ineffective metabolism and elimination of medication. 
Therefore, the geriatric population with CKD is at higher risk of medication overdose, toxicity, 
and ADEs.  
 As the prevalence of MCC increases with age, the geriatric population has a high 
likelihood of being administered and/or consuming a wide variety of medications to manage 
their conditions. Based on a survey taken in 2002, approximately 25% of the overall United 
States population takes at least five or more medications per week (Rambhade, Chakarborty, 
Shrivastava, Patil, & Rambhade, 2012). For the geriatric population 65 years and older, this 
percentage significantly increases to approximately 50% consuming five or more medications 
and 12% taking 10 or more prescriptions per week (Rambhade et al., 2012). Hence, 
polypharmacy is a substantial concern among this population and is associated with increased 
drug costs, poor adherence to medication regimens, ADEs, and hospitalization (Terrery & 
Nicoteri, 2016; Rambhade et al., 2012). Across the United States, polypharmacy and its ADEs 
were responsible for approximately 100,000 emergency hospitalizations in the elderly population 
65 years and older between the years 2007 to 2009 (Terrery & Nicoteri, 2016). Approximately 
$136 billion of medical costs are expended on the treatment of the over 2 million ADRs that 
occur each year (Terrery & Nicoteri, 2016). 
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 As one of the leading sources of information regarding medication safety for the geriatric 
population, the AGS’ Beers Criteria for Potentially Inappropriate Medication Use in Older 
Adults identifies medications that are considered “potentially inappropriate” and should be 
avoided if alternative treatment options such a safer medication, lifestyle changes, or non-
medication therapy are available for use in the elderly population (Health in Aging, 2015). These 
PIMs pose a greater risk than the benefits for the older patient 65 years and older. The Beers 
Criteria is regularly updated as new research is published regarding new medication and the 
safety of already existing treatment methods (Health in Aging, 2015). Utilizing a time-testing 
method for treatment guideline development and following the Institute of Medicine, the Beers 
Criteria was last updated in 2015 after 6,700 high-quality research studies regarding certain PIMs 
prescribed for older adults were reviewed by the AGS’ expert panel (Health in Aging, 2015). 
Although it may be utilized to identify PIMS and prevent ADEs in the elderly population, the 
Beers Criteria is a reference tool and should not replace the healthcare provider’s clinical 
judgment since it does not take into consideration the patient’s unique circumstances. 
Assessment 
 This quality improvement project was implemented at a nephrology specialty practice 
clinic. This practice is currently being operated by a physician and three support staff including 
an office manager, a medical assistant, and a front desk receptionist. Medicare and Medicaid are 
accepted, as well as all other commercial and private insurances. The clinic refers and 
collaborates with primary care and other various specialty practices in order to provide 
comprehensive disease management and care plans for patients aged 65 years and older with 
MCC.  
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Stakeholder Engagement 
 A stakeholder may be defined as an individual or a group of individuals with an interest 
in clinical decisions and improvements related to the evidence supporting these changes (Agency 
for Healthcare Research and Quality, 2014). At this specialty clinic, the main stakeholders would 
consist of the patients and their families, the health care provider and support staff, and payers 
such as employers and insurance companies. The patients’ interests in the clinic as a stakeholder 
stems from concerns in relation to the severity of their conditions, most effective treatments, and 
feasible treatment options in regards to cost, ease of implementation, and maintenance (Agency 
for Healthcare Research and Quality, 2014). Healthcare providers are the decision-makers who 
identify gaps in the literature and utilize the existing research regarding evidence-based practices 
to implement safe and effective treatment options while avoiding harmful interventions (Agency 
for Healthcare Research and Quality, 2014). In order to implement best practice and make safe 
treatment recommendations, a healthcare provider must maintain an appropriate knowledge-base 
and stay current with recent evidence-based guidelines for quality patient care (Agency for 
Healthcare Research and Quality, 2014). Payers attempt to ensure that patients are provided 
quality and evidence-based treatment to expedite healing, optimize normal function, and prevent 
complications that increase direct and indirect medical costs (Agency for Healthcare Research 
and Quality, 2014). Therefore, each and every stakeholder is involved and has a vested interest in 
the use of evidence-based practices, quality improvement, and successful implementation of 
effective medical treatment.  
Assessment of the Organization 
 There are approximately 1,500 patients attending and being seen at this clinic. On 
average, the physician will see approximately 10 patients per day in the afternoon. Only patients 
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of adult age of 18 years and older are seen. The majority of patients are older adults between the 
ages of 62-83 years. Approximately 40% of the patients seen at this clinic are females, and the 
other 60% are males. The majority of the patients are either African-American or Hispanic. 
Approximately 48% of the patients are African-American, 36% are Latino/Hispanic, and 16% 
are Caucasian (non-Hispanic). Common chronic conditions and diagnoses seen at this clinic 
include CKD, diabetes mellitus type 2, hypertension, hyperlipidemia, gastroesophageal reflux 
disease, hypothyroidism, and coronary artery disease. An estimated 80% of the patients seen at 
this practice have CKD. Approximately, 60% of the geriatric population 65 years and older are 
diagnosed with CKD with an estimated 55% of these patients with CKD stage 3 and another 
10% are stage 4. 
Due to the age and comorbidities of the patients seen at this clinic, polypharmacy is 
common. Based on a randomized review of 30 patient charts, approximately 28% of patients are 
taking 3-4 prescription medications and another 60% are taking 5 or more. This is in line with 
the national statistics (Rambhade et al., 2012). Common prescription drugs documented in the 
patients’ charts include tramadol, levothyroxine, allopurinol, amitriptyline, aspirin, diuretics, 
vasodilators, antihypertensive medication, and anti-diabetic medication.  
In addition to polypharmacy, PIMs were identified utilizing the AGS’ Beers Criteria. The 
chart review revealed approximately 53% of patients seen at this clinic take at least one PIM and 
another 17% take two or more PIMs. Identified PIMs include amitriptyline, hydralazine, 
minoxidil, doxazosin, terazosin, clonidine, and diphenhydramine. Besides prescription 
medications, some patients also consume vitamins, electrolytes, and other supplements such as 
sodium bicarbonate, potassium, magnesium, and vitamin B, C, and/or D. Although PIMs have 
been identified, changes to an effective, safer alternative treatment option are not being made to 
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patients’ medication regimens and treatment plans. Therefore, in order to safely and 
appropriately manage geriatric patients with polypharmacy and MCC, evidence-based practices 
indicate that PIMs should be identified and safer alternative treatment options should be 
recommended if the risks outweigh the benefits (Health in Aging, 2015). 
Organizational Readiness for Change 
 The Practice Improvement Capacity Rating Scale (Appendix A) is an instrument for 
identifying and assessing an organization’s readiness to change and to conduct quality 
improvement (QI) activity (Robert Wood Johnson Foundation, 2014). The instrument scores an 
organization or practice with one of the three following colors: red meaning the practice is not 
ready for QI measures, yellow that the practice has limited capacity for change but may in the 
future, and green for the practice being ready and capable for immediate QI implementation 
(Robert Wood Johnson Foundation, 2014). When utilizing this instrument, the first step is to 
determine whom to interview at the chosen organization. Based on the responses from the 
interview, each question is scored based on the criterion and weighted on a scale of 1 to 3 with 1 
being of lowest importance and 3 being of highest importance (Robert Wood Johnson 
Foundation, 2014). All criteria with a weight of 3 is considered a “must-pass” area and must 
receive a green level in order to have a final score in green (Robert Wood Johnson Foundation, 
2014). As the only patient care provider and owner of the clinic, the physician was interviewed. 
Based on his responses, the clinic received an overall score of 250, which was determined by 
multiplying the scored questions by the weighted criterion and adding each category to equal the 
final score. The final score of 255 was at the green level according to the scale indicating that the 
clinic was ready and capable for immediate QI implementation (Robert Wood Johnson 
Foundation, 2014). 
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Project Identification and Focus 
 The purpose of this QI project was to implement the AGS’ Beers Criteria to promote 
medication safety by the identification of potentially inappropriate medications and the 
prevention of medication-related complications among the geriatric population 65 years and 
older with MCC. By implementing the Beers Criteria into the medication reconciliation process, 
the primary objective was to increase the number of charts for geriatric patients 65 years and 
older being reviewed for potentially inappropriate medications from 0% to 80% over a 6-week 
period. The second objective was to increase the number of PIMs that are changed to alternative 
medication or treatment options based on the recommendations of the Beers Criteria from 0% to 
25% over a 6-week period.  
Summary and Strength of the Evidence 
 A literature review was conducted on the topic of the implementation of the AGS’ Beers 
Criteria, polypharmacy, and the identification of PIMs. The literature reviewed was focused on 
the elderly population 65 years and older in various settings and subpopulations to include acute, 
hospitalized patients and outpatient, community-dwelling patients. The overall strength of the 
articles and the AGS’ Beers Criteria are acceptable and reliable sources to be used as evidence in 
support of this QI project.   
Prevalence of PIMS 
 Narayan and Nishtala (2015) conducted a cross-sectional analysis with 559,625 
participants to examine the prevalence of PIMs among the elderly population aged 65 and older 
in the country of New Zealand. Based on this study, PIMs are prevalent in this the geriatric 
population with approximately 40% of patients being prescribed at least one PIM (Narayan & 
Nishtala, 2015). The results of this study identified the highest exposure of PIMs among 65 to 74 
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year old patients and the most commonly identified PIMs to be nonsteroidal anti-inflammatory 
drugs (NSAIDs), benzodiazepines, and amitriptyline (Narayan & Nishtala, 2015). Another study 
conducted by Skaar & O’Connor (2017) concluded with similar results that approximately 57% 
of dental patients aged 65 years and older were prescribed at least one PIM. It was identified that 
the most prevalent PIMs were proton pump inhibitors, NSAIDS, and benzodiazepines with 
common adverse effects of xerostomia, sedation, gastrointestinal bleeding, orthostatic 
hypotension, and falls (Skaar & O’Connor, 2017). Women and patients of lower socioeconomic 
status were also associated with an increased number of PIM prescriptions (Skaar & O’Connor, 
2017). A retrospective study with 523,811 elderly subjects age 65 years and older was conducted 
by Nam, Han, Kim Bae, and Lee (2016) in South Korea. This study identified that common 
predictors of PIM prescriptions included the age of 65 years and older, the female sex, 
polypharmacy, MCC, and the severity of these chronic conditions (Nam et al., 2016). Nam et al. 
(2016) also identified a potential cause for the high prevalence of PIM prescription to be “doctor-
shopping” from one physician to another without a system or process to inhibit such patient 
activity.  Therefore, based on these studies, there is an issue with the prevalence of PIMs among 
the geriatric population with increased risk based on gender, socioeconomic status, MCC, 
polypharmacy, and poor health conditions.  
AGS’ Beers Criteria vs. STOPP/START 
 Boland et al. (2016) conducted a randomized control trial with 20 patients aged 65 years 
and older at a teaching hospital in Ireland to compare the Beers criteria and Screening tool of 
Older Persons’ Prescriptions/Screening Tool to Alert to Right Treatment (STOPP/START) in 
terms of the tools’ impact on the incidence and identification of PIMs among older adults. The 
findings indicated the Beers Criteria to be highly effective in identifying PIMs and reducing 
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polypharmacy among older adults; however, the STOPP/START showed to be slightly more 
superior in identifying PIMs in this population (Boland et al., 2016). A similar study was 
conducted in China to compare the Beers Criteria with the STOPP criteria in assessing and 
identifying PIMs among older adults. This retrospective cross-sectional study with 6,337 
participants showed the Beers Criteria had a higher detection rate of PIMs and was more 
sensitive in assessing PIM use (Li et al., 2017). Despite the conflicting results of these two 
studies, both studies show that the Beers Criteria is an effective and reliable tool for the 
screening and identifying of PIMs in the geriatric population 65 years and older.  
 Zeenny et al. (2017) conducted a cross-sectional observation study with a secondary 
objective to compare PIM prevalence rates as per the Beers Criteria 2003 and 2012 version. In 
this study consisting of 248 patients aged 65 years and older, a high prevalence of PIMs was 
identified utilizing both the 2003 and 2012 version of the Beers Criteria (Zeenny et al., 2017). 
However, the study results identified the Beers Criteria of 2012 to be the more effective version 
of this tool in identifying PIMs due to its significantly higher percentage of PIM identification 
among the sample in comparison to the 2003 version; 45.2% with the Beers Criteria 2012 versus 
27% with the 2003 (Zeenny et al., 2017). Unlike the 2003 version, the effectiveness of the Beers 
Criteria of 2012 in PIM identification is associated with its classification of PIMs in the 
following three categories: 1) PIMs and the classes of medication to avoid in the older adult 
population, 2) PIMs and medication classes to avoid in older adults with certain disease and 
syndromes that the medication may exacerbation, and 3) medications to be used with caution in 
the older adult population (Alhmoud, Khalifa, & Bahi, 2015; Zeenny et al., 2017).  
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Benefits and Limitations of the Beers Criteria 
 Although there are no national guidelines requiring the utilization and implementation of 
the AGS’ Beers Criteria in the treatment and management of geriatric patients 65 years and 
older, the evidence supports the effectiveness of the Beers Criteria in identifying PIMs and the 
need to implement it due to the prevalence of PIM use and PIM predictors in the geriatric 
population. The PIMs listed on the Beers Criteria are associated with more risks and adverse 
health outcomes such as increased hospitalization, mortality, gastrointestinal bleeding, falls, 
fractures, and other ADEs (Narayan & Nishtala, 2015). 
 Although the Beers Criteria is a valuable reference tool for the promotion of medication 
safety, this tool does have limitations. One limitation is that the Beers Criteria is a reference tool 
to identify PIMS and to prevent ADEs in the elderly population that does not take into 
consideration the patient’s health status and unique circumstances. Therefore, this tool should not 
replace the healthcare provider’s clinical judgment. According to Alhmoud et al. (2015), another 
limitation is the Beers Criteria’s inclusion of medications that are not considered to be 
contraindicated in the geriatric population by other updated and evidence-based drug formularies 
such as the British National Formulary. Despite these limitations, the Beers Criteria remains a 
valuable tool in the identification of PIMs in order to prevent health complications and ADEs 
among the vulnerable population of elderly patients 65 years and older with MCC. 
Methods 
Project Intervention 
 In order to properly implement the Beers Criteria and identify PIMs in the geriatric 
population aged 65 years and older at this nephrology specialty clinic, the physician and office 
staff were educated regarding the QI measure and their designated role in the implementation 
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process. Before the intervention plan was initiated, a 30-minute education session was scheduled 
during the clinic’s lunch hour when all staff members were gathered in one location. During this 
education session, the staff was educated via a PowerPoint presentation regarding the prevalence 
and identification of PIMs in the elderly population 65 years and older with additional risk 
factors such as MCC and polypharmacy increasing this population’s risk of experiencing ADEs. 
Hence, the staff was made aware of the need to implement the AGS’ Beers Criteria in order to 
promote patient safety and improve quality of care. The Beers Criteria and its purpose as a 
reference tool to guide a healthcare provider’s treatment plan to promote medication safety was 
explained. Although the physician was not required to change a medication that was identified as 
a PIM by the Beers Criteria if deemed unnecessary, the physician was prompted to review all 
identified PIMs and validate the need to continue or change. The staff was also instructed and 
trained to fulfill their designated role in the implementation process. Education materials were 
provided to each staff member, which included a flow sheet of the intervention process 
(Appendix B), a pocket guide of the Beers Criteria, and a copy of the PIM Identification 
checklist (Appendix C). In addition to providing the Beers Criteria pocket guide to each staff 
members, the DNP student placed a copy of the pocket guide in each of the patient rooms in 
order for it to be readily accessible to both the MA and physician. See Appendix D for additional 
details regarding the intervention process and the estimated costs of education materials.  
 The intervention process began with the patient attending their regularly scheduled 
appointment. At the start of each patient’s appointment, the front desk receptionist checked-in 
the patient and determined if the patient is eligible to participate in the QI project. The eligibility 
criterion was the geriatric patient 65 years or older with all current medications and herbal 
supplements. The clinic requires that all patients bring all medications and supplements that they 
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are currently consuming.  If the patient met this criterion, the front desk receptionist placed the 
PIM Identification checklist with the patient’s name and date of birth in the patient chart to be 
filled out by the medical assistant and physician. The PIM Identification checklist was designed 
by the DNP student and utilized as a documentation tool to note the medical assistant’s 
completion of tasks and to document the physician’s clinical judgment regarding a patient’s 
medication regimen.  
 Once the patient was checked-in, the medical assistant proceeded with the normal process 
of weighing, obtaining vital signs, and documenting the patient’s current medications and 
supplements in the chart. Documentation of all medications included the medication name, dose, 
frequency, and route that the medication was being taken. After the patient’s medications were 
documented, the medical assistant compared the list of the patient’s medications with the Beers 
Criteria. All medications that met the Beers criteria were noted identifying these medications as 
PIMs that needed to be reviewed by the physician. Once the MA completed these tasks, he 
placed a check next to each of the tasks that were completed documenting on the checklist that 
the intervention process was followed as planned.  
 After entering the patient room, the physician received the patient’s chart with the 
checklist and the patient’s medication documented inside the chart. Based on the patient’s 
medical history, health status, and the awareness of any PIMs that the patient was consuming, the 
physician evaluated the patient’s treatment plan and determined whether to continue with the 
current medication regimen or recommend an alternative treatment option. In addition to the 
physician’s SOAP note documented in the chart, his decision regarding treatment was 
documented on the checklist by circling one of the following options: “Continue with same 
treatment” or “Recommend alternative treatment.” If the physician chose to continue with the 
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same treatment plan and medication regimen, the checklist provided a section for the physician 
to indicate the rationale for his decision or why the patient will continue with the same therapy. 
Similarly, if the physician changed medications or chose an alternative treatment option, the 
physician documented these changes and his rationale for the change in the patient’s treatment 
plan. All changes in the patient’s treatment plan or medication regimen were documented on 
either the patient’s chart or the checklist documented on the patient’s chart. It was essential to 
document these changes in the patient’s chart for the physician’s use to recall the change that 
was made and for the office’s use to provide refills as needed. Later, for data collection and 
analysis, the DNP student noted any changes in treatment that were made at the time of the visit 
and documented these changes onto the checklist for data collection. For the physician’s 
convenience, the checklist included rationales that simply needed to be circled to document the 
physician’s rationale for choosing one of the above-mentioned options. If the rationales on the 
checklist did not pertain to his decision, the physician manually documented his decision and 
wrote out his rationale on the “Other” option.  
 At the end of the patient’s scheduled appointment, the front desk receptionist received the 
patient’s chart and checked-out the patient. The PIM identification checklist was removed from 
the patient’s chart and placed in a designated folder for data collection and analysis. At the end 
of each week, the DNP student collected the checklists and formulated a census of all eligible 
patients scheduled for an appointment at the clinic during the week. Utilizing the patient 
identification on the checklists, the DNP student pulled all the charts of each eligible patient who 
participated in the QI measure and had a checklist completed regarding their treatment plan. 
Once the charts were pulled, the census was used to determine the percentage of patients who 
were scheduled, met the eligibility criteria, and were provided a checklist to review their 
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medication list with the Beers Criteria. In addition to determining the percentage of patients’ 
medication regimens reviewed with the Beers Criteria, the checklist was utilized to evaluate the 
number of PIMs that are changed to an alternative treatment based on the Beers Criteria 
recommendations. The DNP student conducted a weekly review of the patient’s charts and PIM 
Identification checklist to assess the patient’s medications, chronic conditions, and notation of 
PIMs. For each PIM that was identified, the DNP student assessed if the physician chose to 
maintain or alter the patient’s treatment plan. See Appendix E for data collection table.  
 In order to confirm that the QI measure was progressing as planned and sustainable, a 30-
minute staff meeting was scheduled at the halfway point of the implementation process to review 
progress, answer questions, and improve processes of the project as needed. The staff meeting 
was held during the office’s lunch hour to ensure that all staff members are present. During this 
meeting, the DNP student presented the results gathered since the start of implementation, 
suggested methods to improve the implementation process, and addressed any questions or 
concerns that the staff had. During the implementation process if the DNP student identified an 
issue with the QI project or the implementation process, the DNP student addressed the issue by 
reminding the staff member regarding their role in the process and be willing to schedule 
additional staff meetings as needed to address any issues or concerns. The last staff meeting was 
held at the conclusion of the QI measure when the DNP presented the final results of the project 
and thanked the staff for their endeavor in improving patient care.  
Organizational Barriers and Facilitators 
 This specialty clinic possesses numerous strengths that facilitated the successful 
completion and sustainability of this quality improvement measure. The physician recognized the 
issue of PIMs in the geriatric population, acknowledged the relevancy of this QI measure in his 
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practice, and was willing to participate in the project intervention. The clinic is a small practice 
with only one physician and three office personnel that collaborate with one another to 
effectively operate the clinic and to provide safe, quality care to patients. In addition to being a 
small practice, trust is apparent in the strong relationship between each of the members of the 
healthcare team at this clinic, which promotes collaboration and improves overall patient care. 
The office staff is well-trained in their individual roles and has a strong work ethic that motivates 
each member to accomplish their assigned tasks. Due to the healthcare team’s collaboration, the 
practice operates efficiently with short wait times for patients and lessened burden on the 
physician to micromanage his support staff. The physician is adamant regarding scheduling 
ample appointment time for each patient and providing each patient the time and attention 
needed to thoroughly assess and manage the complexity of these patients. Therefore, the clinic 
also has a strong and positive reputation in the community and among patients; there is a 
facilitation of trust and rapport between the patients, families, physician, and support staff.  
Although the physician does not speak the Spanish language, the office manager and 
medical assistant are proficient in the language. The clinic is located in an area with a large 
Hispanic population; and there is a large percentage of Hispanic patients seen at this practice. 
The office staff’s proficiency in the Spanish language facilitates trust and builds rapport between 
patients seen at the clinic who may speak English as a second language or are only Spanish-
speaking. Lastly, this QI measure was easily implemented into the practice’ medication 
reconciliation process and was also cost-effective with minimal expenses needed to fund the 
intervention.  
 Despite these strengths, there were also weaknesses and barriers that hindered this QI 
measure. There was a lack of awareness and familiarity regarding the Beers Criteria. The initial 
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implementation of the Beers Criteria in the practice’s medication reconciliation process was a 
change that required supervision, reminding, and short period of adjustment for this transition. 
The practice has not transitioned to electronic health records (EHR) and still utilizes the paper 
chart. In comparison to the EHR, paper charting is a time-consuming process of locating, sorting, 
and organizing these patient charts that prolonged the implementation and data collection 
process.  
As a small practice, the healthcare team has strong relationships with one another and 
effectively collaborates; however, this also presents an issue. With only one physician to provide 
patient care and three support staff with differing roles to operate the office, the absence of one 
member will short-staff the office. The physician is only available at the clinic in the afternoon; 
therefore, patients can only be scheduled between 2:00 p.m and 5:00 p.m.  
The staff’s proficiency in the Spanish language may facilitate communication with 
Spanish-speaking patients; however, they are not professionally certified medical translators. 
This may be an issue as the staff may be unable to translate the physician’s instructions to the 
patient with complete accuracy.  
As a specialty practice that cares for chronically ill patients with MCC, many of these 
patients have been attending this practice and receiving care from the physician for several years. 
Therefore, these patients have been stabilized and compliant with the same medication regimen 
with no ADEs. The physician and patients were hesitant to alter a medication regimen that has 
effectively and safely improved and stabilized a patient simply due the Beers Criteria identifying 
a PIM in the patient’s regimen. In addition to the hesitancy to alter an effective medication 
regimen, the physician is a nephrologist that operates a specialty practice for treating and 
managing renal disorders. The physician was reluctant and uncomfortable with discontinuing a 
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medication prescribed by another physician and altering the treatment for a condition that is not 
within his specialty. Other potential issues of switching to a newer or safer alternative treatment 
option included patient refusal, the cost of purchasing a new medication, insurance coverage for 
the medication, availability of the medication, and the effectiveness of this alternative option. 
Ethical Considerations 
 During the implementation of this QI measure, it was essential to identify and address 
any and all ethical concerns. The primary ethical consideration of this QI measure was patient 
confidentiality. The intervention process required that the patient’s name and date of birth be 
written on the checklist in order for the DNP student to identify the patient and pull the 
appropriate chart to evaluate the project outcomes. In order to maintain patient confidentiality, a 
confidentiality form was signed by the physician and the DNP student granting access to patient 
information and charts. Also, all material containing patient information was only accessible to 
the office staff and those granted permission by the physician via the confidentiality form. 
During the intervention process, the folder containing the checklist was kept by the front desk 
reception during office hours and stored in the chart room that was locked for closing hours. All 
checklists with the patients’ personal information were properly disposed of in the practice’s 
paper shredder at the conclusion of the QI measure. In addition to the confidentiality form, the 
physician also wrote and signed a letter of support allowing the DNP student to utilize the 
facility as a site for this QI measure (see Appendix F).  
 In addition to patient confidentiality, the patient’s socioeconomic status was another 
ethical concern taken into consideration. For this QI measure, an objective was to promote safety 
by altering PIMs for a safer alternative treatment option. Although an alteration of treatment may 
promote safety, it may also raise financial concerns for patients of low socioeconomic status. 
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Therefore, when evaluating the patient’s treatment plan, the physician took into consideration the 
patient’s safety, current health condition, socioeconomic status, and insurance coverage. If the 
patient was unable to access the alternative treatment option due to cost, lack of insurance 
coverage, or unavailability of medication, the physician often had to continue with the same 
treatment plan if the patient was content and not experiencing ADEs. Besides cost, another 
ethical consideration was the effectiveness of alternative treatment. If the patient was on a stable 
treatment plan or alternative treatment was not as effective as the PIM, the physician often 
deemed that the benefits outweighed the risk and chose to continue with the same treatment plan. 
The alternative treatment option was only recommended if the treatment was effective and 
benefits outweighed the risk for the patient’s health and safety.  
Budget 
 Unfortunately, there are no national guidelines requiring the implementation of the Beers 
Criteria in the treatment and management of geriatric patients. The physician and his practice 
were unable to charge and receive reimbursement for this intervention. Therefore, there was no 
financial incentive for physician and the office staff’s participation in this QI measure. There 
were minimal costs associated with the implementation of this QI measurement. The expenses 
for this project included the teaching material (4 flow sheets, 6 Beers Criteria pocket guides, 4 
PIM Identification checklists), 120 PIM Identification checklist for the intervention process, the 
confidentiality folder, and meals for the education sessions and staff meetings. The costs for the 
purchase and printing of materials necessary for this intervention are as follows:  
• $50 for each meal provided at the education session and staff meetings  
o Three scheduled meetings at the start, mid-way point, and conclusion of this 
project.  
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• Cost of purchasing and printing material for intervention
o $2 for the Confidentiality folder
o $10 for the paper and cost of printing material
• Total cost equaled $162.00
In comparison to the cost of hospitalization or treatment of other ADEs, this project was a 
cost-effective intervention that served as a QI measure to promote patient health outcomes and 
prevent ADEs. 
Results 
A total of 112 eligible patients aged 65 years and older with all current medications and a 
scheduled appointment at the time of the intervention were included in this QI measure. Patients 
who failed to attend their scheduled appointment or bring all current medications to their 
appointment were excluded from this intervention. Among the 112 participants, the average age 
was 75.3 years. The majority of the participants seen at this clinic were of the female gender and 
non-Hispanic African-American patients. The most common type of insurance seen at this 
practice was Medicare followed by private insurance companies. Polypharmacy was a common 
factor among the participants; the average number of prescribed medications was 7 medications. 
The mean number of MCC was 5.19 chronic conditions. All (100%) of the participants were 
diagnosed with at least one of the following chronic conditions: hypertension, diabetes mellitus 
type 2, and chronic kidney disease. Of these patients, 79.61% (82/103) were diagnosed with 
more than one of these conditions. The demographic results are presented in Table 1.  
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Table 1. Sample Characteristics 
Characteristics 
Age, mean 
Age, range 
75.3 
65-90
Sex, n (%) 
 Male 
 Female 
37.5% 
62.5% 
Race, n (%) 
 White, non-Hispanic 
 African-American, non-Hispanic 
 Hispanic 
13.39% 
52.68% 
34.95% 
Insurance, n (%) 
 Medicare 
 Dual Eligible (Medicare/Medicaid) 
 Private Insurance 
        Aetna 
        Humana 
        BCBS 
58.25% 
4.85% 
11.65% 
6.78% 
20.39% 
Multiple Chronic Conditions, mean 5.19 
Multiple Chronic Conditions, range 2-9
Number of Medications/Polypharmacy, 
mean 
7 
Number of Medications/Polypharmacy, 
range 
2-20
 This QI project had two objectives for which data was collected, analyzed, and evaluated 
for separately. The first objective was to increase the number of eligible patients aged 65 and 
above having their medication list reviewed with the Beers Criteria at each office visit from 0% 
to 80%. The PIM Identification checklist (Appendix C) was utilized by the medical assistant and 
physician as a “trigger” to review the medication list with the Beers Criteria and recommend 
alternative treatment as needed. Of the 112 patients eligible to participate in this QI measure, 103 
of these patients had their medication list reviewed by the Beers Criteria during their scheduled 
appointment. This is a 91.3% (103/112) increase from the baseline of 0%, which exceeds the 
target goal of 80%. PIMs were identified and noted in 57.2% (59/103) of the patients charts that 
were reviewed with the Beers Criteria. In this PIM group (patients with identified PIMs using the 
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Beers Criteria), 79.66% (47/59) had at least one identified PIM that the patient was currently 
consuming. Another 20.34% of these PIM group patients had two or more PIMs identified in 
their medication list. The prevalence of PIMs increased with the female gender, the number of 
chronic conditions, and increasing age. The most common types of PIMs identified using the 
Beers Criteria were benzodiazepines (15.25%), first-generation antihistamines (11.86%), 
sulfonylureas (11.86%), and nonsteroidal anti-inflammatory drugs (NSAIDs) (11.86%). Table 2 
lists the top 10 categories of PIMs identified by reviewing the patients’ medication lists using the 
Beers Criteria.  
The second objective was to increase the number of PIMs changed to an alternative 
medication or treatment option from 0% to 25% based on the Beers Criteria recommendations. 
Of the 59 patients with PIMs identified in their medication list, only 7 of these patients had the 
identified PIM(s) changed to an alternative medication or treatment option. Although it does not 
meet the goal of the second objective, it is an 11.8% increase from the baseline of 0%. The most 
common rationales for not changing the PIM and utilizing an alternative treatment option were 
patient refusal (25%), need for consultation with the physician who prescribed the PIM 
(15.83%), and the effectiveness of the current medication regimen without ADEs (53.85%).   
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Table 2. Beers Criteria Implementation and Identification of PIMs 
 n (%) 
Medication List reviewed with Beers 
Criteria 
91.3% 
Medication List with Identified PIMs                  57.2% 
Number of Identified PIMs 
     At least one PIM 
     Two or more PIMs 
 
79.66% 
20.34% 
PIMs among Gender 
     Female 
     Male 
 
54.69% 
48.98% 
Top 10 Most Common PIMs 
     Benzodiazepines 
     Hormone Replacement 
     Amitriptyline 
     Amiodarone 
     Alpha-2 Agonist 
     NSAIDs 
     Antidepressants 
     Muscle Relaxants 
     1st Generation Antihistamines 
     Sulfonylureas 
     Vasodilators                                                              
 
15.25% 
10.17% 
8.47%         
3.39% 
8.47% 
               11.86% 
3.39% 
8.47% 
11.86% 
11.86% 
3.39% 
 
  Throughout the duration of this QI measure, all data was collected for the purpose of 
analyzation and evaluation via a data collection spreadsheet on Microsoft Excel (Appendix E). 
Each of the objectives were evaluated by calculating and comparing the percentage changes from 
pre- and post-intervention. The mean and/or range of a variable were calculated using Microsoft 
Excel.  
Discussion 
 The QI intervention aimed to promote medication safety and to prevent medication-
related complications by implementing the Beers Criteria into the medication reconciliation 
process to identify PIMs in geriatric patients aged 65 years and older. The Beers Criteria was not 
utilized prior to this intervention. A total of 103 patients (91.3%) had their medication list 
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reviewed with Beers Criteria, which is a significant increase that surpassed the goal of the first 
objective. At the start of the intervention, the practice struggled with the change of implementing 
a new step into their medication reconciliation process and failed to review the medication list of 
five eligible patients. Once the staff was able to adjust to the change, there was improvement in 
placing the PIM Checklist in patient charts to trigger the medical assistant to utilize the Beers 
Criteria and the physician to review the patient’s treatment plan. According to the front desk 
receptionist, the failure to review an eligible patient’s medication list with the Beers Criteria was 
her fault for not placing the PIM Checklist in the patient’s chart. She stated this failure to fulfill 
her task was due to patients that were worked into the evening schedule that morning and she 
was unable to prepare the patients’ charts with the PIM checklist the evening before, which is her 
usual process of patient chart preparation. Recommendations for addressing this concern would 
be to maintain the current process, but also have the PIM checklist readily available for last 
minute schedule additions. See Figure 1 for the weekly progression of this QI intervention.  
 
Figure 1. Intervention Progress over 6-Week Period. This figure illustrates the weekly census of 
eligible patients and the weekly progression of implementing the AGS’ Beers Criteria to review 
the patients’ medication lists for PIMs.  
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 The prevalence of PIMs was relatively high; 57.2% of patients had at least one PIM 
identified in their medication list. This prevalence increased with the increasing number of 
chronic conditions, the increasing age of a patient, and among the female gender. These findings 
are consistent with previous studies conducted by Narayan & Nishtala (2015), Skaar & 
O’Connor (2017), and Nam et al. (2016). The study conducted by Narayan & Nishtala (2015) 
identified the most common types of PIMs to be NSAIDs, benzodiazepines, and amitriptyline. 
Similarly, for this QI intervention, the top four most commonly identified PIMs were 
benzodiazepines, NSAIDs, first generation antihistamines, and sulfonylureas. As an individual 
ages, the older adult experiences numerous age-related physical changes leading to the diagnosis 
of more chronic medical conditions and the need for more medication to manage these 
conditions. Therefore, it is essential for healthcare providers to seriously consider medication 
safety, drug-disease interactions, and non-drug treatment options for this vulnerable population 
before prescribing additional medications.  
 The use of alternative medication or treatment options were relatively low in comparison 
to the prevalence of PIMs. The most common rationale for not changing the PIM to an 
alternative treatment was the effectiveness of the current medication regimen without ADEs and 
the benefits of the regimen outweighing the risks. Due to the complexity and chronicity of these 
patients’ conditions, the physician was limited in the selection of treatment and unable to alter 
the patient’s medication regimen. In such cases, the physician would not change the PIM that has 
stabilized and effectively managed the patient’s conditions for years. Increasing age was another 
factor that contributed to the lack of alternative treatment use. The older the patient’s age, the 
more reluctant the patient became to alter a medication regimen that was effective in managing 
the chronic conditions. Therefore, patient refusal was another common reason for not altering a 
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medication regimen. There were various reasons for patient refusal including financial concerns, 
lack of insurance coverage, familiarity with the current regimen, or simply due to the years of 
effective management with their current treatment plan. The physician is a nephrologist that 
specializes in the treatment and management of renal disorders and other chronic conditions 
associated with renal disease such as hypertension, diabetes mellitus, and hyperlipidemia. The 
physician was reluctant to discontinue a medication prescribed by another physician and treat a 
condition that was not within his specialty. Instead, the physician chose to consult the physician 
who prescribed the PIM or have the patient discuss with that physician regarding the PIM and 
other alternative treatment options.  
Limitations 
Several limitations should be noted in this QI intervention. First, the health conditions of 
the patients that participated in this intervention. Due to the complex nature of these patients’ 
health conditions, treatment and management of their various conditions were often intense and 
individualized for each patient. As a result, the physician was unable to change to the PIM to an 
alternative medication for several patients because the PIM was vital in stabilizing the patient’s 
chronic condition and optimizing health outcomes. Second, the clinic was a specialty practice. 
Although the physician did collaborate and consult with the physicians who prescribed the PIM, 
this intervention may have been more effective in a primary care setting that functions as the 
“gatekeeper” of the various specialties seen by a patient.   
Recommendations 
 Based on the results of this QI measure, it is recommended to implement the intervention 
of reviewing the medication lists of all patients aged 65 years and older with the Beers Criteria in 
a primary care setting. Although an effective intervention when implemented in a specialty 
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practice, the physician deemed this intervention would be more effective in a primary care 
setting due to his reluctance to discontinue medication for a condition that was not within his 
specialty. The physician did consult with the prescribing physician regarding alternative 
treatment or advised the patient to discuss alternative treatment options with the physician. 
However, the role of a primary care provider (PCP) is to provide treatment and preventive care 
across a life span. If the Beers Criteria were implemented in a primary care setting, a PCP could 
prevent the use of PIMs before reaching the age of 65 years and older. In situations where a PIM 
was identified for a geriatric patient, the PCP could alter the PIM as appropriate or function as 
the gatekeeper promoting collaboration with the various physicians and specialties caring for the 
patient in order to promote wellness and prevent complications.  
 In terms of continuing this project at the current practice, it was a relatively easy and 
simple intervention that added one additional step to the practice’s already-existing medication 
reconciliation process. The additional step was to review the medication list documented in the 
patient’s chart with the Beers Criteria and notate any PIMs that were identified. Due to this 
simplicity and the easy adaptability into the medication reconciliation process, the intervention 
should be easily sustainable at this practice. Furthermore, after this 6-week period, the 
intervention has become embedded into the practice’s culture. The PIM Identification Checklist 
served as a trigger to remind the medical assistant of the process until it became a part of the 
culture. However, it is recommended that the practice format the PIM Checklist according to 
their needs, such as removing the requirement for physician rationale that was pertinent to only 
this project, and continue to utilize the checklist for the sustainability of this intervention.  
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Implications for Practice 
The purpose of the Beers Criteria is to identify potentially inappropriate medications that 
present a higher risk for ADEs and other medication-related complications when used in the 
geriatric population. By increasing awareness of the Beers Criteria and implementing it into the 
medication reconciliation process, healthcare providers are able to identify PIMs and consider 
safer alternative medication or non-drug treatment options. These actions of identifying potential 
harm and considering alternatives promote medication safety in this vulnerable population. 
Alteration of treatment for any identified PIM is not required; however, this intervention 
promotes patient safety by identifying the potential hazards and reminding the healthcare 
provider to carefully consider the risks and benefits of treatment for the patient. Overall, this 
project was implemented as quality improvement intervention to increase the quality of patient 
care, promote patient safety through safe medication use, and optimize patient outcomes by 
preventing ADEs.  
In addition to promoting overall patient safety and optimizing health outcomes, this 
project promotes inter-professional collaboration and facilitates communication between the 
patient and physician. The identification of a PIM prompted the physician to discuss treatment 
options and compare the risk versus the benefits of the PIM with the patient. If the patient was 
willing to consider alternative treatment not within the physician’s specialty, he would advise the 
patient to discuss these options with the physician who prescribed the PIM or he would 
personally consult with that physician regarding the PIM. Although a simple intervention 
implemented to promote safety and improve health outcomes, this project demonstrated the 
potential of improving communication and collaboration among PCPs, specialty practices, 
pharmacists, dietitians, and other members of a healthcare team.  
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 A Doctorate of Nursing Practice (DNP) prepared nurse is trained to be leader who 
possesses a wide array of knowledge in the sciences and translates this knowledge into practice 
to improve patient care (American Association of Colleges of Nursing [AANC], 2006). At the 
doctorate level, a nurse should possess the ability to assess an organization, identify issues within 
a system, and facilitate change within an organization’s processes (AANC, 2006). According to 
the AANC (2006), the facilitation of change should originate from the knowledge of diverse 
sources and disciplines that is translated into practice in order to solve practice problems and 
improve health outcomes. In addition to assessing for the need for change and facilitating 
change, the DNP-prepared nurse should also be able to develop an intervention process, 
implement the intervention, and evaluate the process through observation, data collection, and 
analysis. The DNP-prepared nurse is also trained to possess leadership skills to establish and 
facilitate collaboration among a healthcare team.  It is essential for the DNP-prepared nurse to 
possess this wide array of knowledge and these various skills sets in order to implement QI 
measures within an organization and effectively promote change. For this project, the DNP 
student had to demonstrate knowledge in the areas of physiological changes in the aging process, 
pharmacologic safety in the geriatric population, and the evidenced-based practices utilizing 
published clinical guidelines, in this case, the Beers Criteria. The AANC’s DNP essentials and 
role were also exemplified by the DNP student when the problem was identified, an action plan 
was developed, the intervention was implemented, and progress of the intervention was 
evaluated via data collection and analysis. The project took coordination and collaboration 
between various areas of clinical practice in order to have a successful implementation, 
evaluation of results, and working to develop sustainability for the practice change. This is the 
definition of the doctoral nursing practice.  
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Appendix A 
Practice Improvement Capacity Rating Scale 
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 Appendix B 
Project Intervention Flow Chart  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Physician 
enters room; 
patient care 
begins 
MA initials all 
completed 
tasks on the 
checklist 
All PIMs are 
noted for 
physician 
review 
MA reviews 
med list with 
Beers 
Criteria 
 
Patient 
check-in at 
front desk 
All eligible 
patients 
receive 
checklist 
Patient 
called to 
exam room; 
vital signs  
MA 
documents 
patient’s 
medication 
Physician assesses 
patient and 
reviews 
medication/tx plan 
Physician 
documents to 
continue or alter tx 
on checklist 
DNP student 
will collect all 
checklists each 
week  
Each week, DNP 
student 
formulates census 
of all eligible and 
scheduled patients  
Data collection 
and analysis for 
evaluation plan 
by DNP student 
Utilizing checklist, 
DNP student will 
pull charts for 
evaluation 
If applicable, physician 
documents alternative 
treatment on SOAP 
note and checklist 
Patient checkout; 
checklist removed 
from chart placed 
in folder 
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 Appendix C 
PIM Identification Checklist 
PIM IDENTIFICATION CHECKLIST 
Name: ______________________________  Age: ______y.o. 
DOB: ____________  Ethnicity: __________  Gender: M / F   
___  1. List of patient’s current medications and supplements documented in 
the patient’s chart.  
 
___  2. Patient’s medications compared AGS’ Beers Criteria 
 
___  3. All PIMs have been highlighted for physician evaluation.  
 
___  4. Physician’s treatment plan documented with rationale.  
A. Continue with same treatment 
a. Treatment effective; no ADEs and benefits outweigh risks 
b. Consult with physician who prescribed PIM 
c. Patient refuses alternative treatment  
d. OTHER: _____________________________ 
B. Recommend alternative treatment 
a. PIM identified; safe and effective alternative treatment 
available 
b. Patient experiencing ADE 
c. OTHER: ______________________________ 
**Please place checklist in the folder located at the front desk. ** 
 
Patient meets criteria (65 years and older): Yes // No 
Chronic diseases: HTN / DM2 / HLD / CKD / Other: _____________ 
Number of prescription medications: __________________________ 
Number of identified PIMs: ____ // Name: _____________________ 
 
 
 
 
 
PIM IDENTIFICATION CHECKLIST 
Name: ______________________________  Age: ______y.o. 
DOB: ____________  Ethnicity: __________  Gender: M / F   
___  1. List of patient’s current medications and supplements documented 
in the patient’s chart.  
 
___  2. Patient’s medications compared AGS’ Beers Criteria 
 
___  3. All PIMs have been highlighted for physician evaluation.  
 
___  4. Physician’s treatment plan documented with rationale.  
A. Continue with same treatment 
a. Treatment effective; no ADEs and benefits outweigh risks 
b. Consult with physician who prescribed PIM 
c. Patient refuses alternative treatment  
d. OTHER: ______________________________ 
B. Recommend alternative treatment 
a. PIM identified; safe and effective alternative treatment 
available 
b. Patient experiencing ADE 
c. OTHER: _______________________________ 
**Please place checklist in the folder located at the front desk. ** 
 
Patient meets criteria (65 years and older): Yes // No 
Chronic diseases: HTN / DM2 / HLD / CKD / Other: _____________ 
Number of prescription medications: __________________________ 
Number of identified PIMs: ____ // Name: _____________________
ALTERNATIVE TREATMENT OPTION: 
 
 
ALTERNATIVE TREATMENT OPTION: 
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 Appendix D 
Action Plan for Project Intervention  
Table 1 
 
Action Plan 
Task Materials Space Finance / 
Budget 
Time Frame Personnel 
 
Preparation of material 
for education session and 
QI measure 
Beers Criteria pocket 
guide, intervention plan 
flow sheet, checklist, 
designated 
confidentiality folder 
DNP student’s 
home/Printing 
store 
Cost of paper 
and printing of 
teaching 
material for the 
education 
session 
• 4 flow 
sheets 
• 6 Beers 
Criteria 
pocket 
guides 
• 4 
checklists 
for 
meeting; 
100 
checklist 
total for 
the 
project 
WEEK 0 
 
Complete one week 
before initiation of QI 
measure 
 
4 hours for preparation 
of all materials needed;  
Complete one week 
before initiation of QI 
measure 
DNP student 
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 Cost for 
printing-
$10.00 
Arrange an education 
session/meeting to 
introduce QI measure to 
staff 
N/A—inform staff of 
the upcoming meeting 
Office No associated 
cost 
WEEK 0 
Complete one week 
before initiation of QI 
measure 
 
Verbally inform staff of 
meeting; 1 min 
DNP Student 
Obtain buy-in and input 
of staff regarding QI 
measure 
N/A—communication 
with staff 
Office No associated 
cost 
WEEK 0 
Complete one week 
before initiation of QI 
measure 
 
Communication with 
staff regarding QI 
project; 20 mins 
 
DNP student 
and staff 
Education 
Session/Introduction of 
QI measure to staff 
Beers Criteria pocket 
guide, intervention plan 
flow sheet, checklist 
Office’s break 
room during the 
staff’s lunch 
hour 
 
Meal ($50 
each meal); 
Cost of paper 
and printing of 
teaching 
material for the 
education 
session 
• 4 flow 
sheets 
• 6 Beers 
Criteria 
WEEK 0 
Complete 3 days before 
initiating QI measure  
 
30-min education 
session before initiating 
QI project 
 
All staff 
members—MD, 
MA, OM, and 
front desk 
receptionist 
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 pocket 
guides 
• 4 
checklists 
for 
meeting; 
100 
checklist 
total for 
the 
project 
• Cost for 
printing-
$10.00 
Place copies of checklist 
at the front desk for 
patient check-in 
Checklist Lobby/Front 
Desk 
Cost of 
printing the 
checklist 
WEEK 0 
Complete one day 
before initiating QI 
project; 1 min  
 
DNP student 
Place copies of Beers 
Criteria pocket guide in 
patient exam room for 
MA  
Beers Criteria pocket 
guide 
Patient exam 
room  
Cost of 
printing the 
Beers Criteria 
pocket guide 
WEEK 0 
Complete one day 
before initiating QI 
project; 1 min  
 
DNP student 
Place confidential folder 
for checklist at front desk  
Designated folder for 
confidentiality of 
checklists  
Lobby/Front 
Desk 
Cost of folder  
($2.00) 
WEEK 0 
Complete one day 
before initiating QI 
project; 1 min  
DNP student 
Patient Intervention 
Process 
Sign-in sheet, patient 
chart, PIM 
Office Employee 
payment; cost 
WEEK 1-6 DNP student 
and all staff 
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 Identification checklist, 
appointment book 
of purchasing 
and print of 
materials—
checklist, 
Beers Criteria 
pocket guide, 
folder 
• Week 1: Jan 29-
Feb 1 
• Week 2: Feb 5-
Feb 8 
• Week 3: Feb 12-
15 
• Week 4: Feb 19-
22 
• Week 5: Feb 26-
March 1 
• Week 6: March 4-
March 8 
 
6-week period of the 
intervention process 
members—MD, 
MA, OM, and 
front desk 
receptionist 
• Check-in patient • Sign-in sheet, 
patient chart, copy 
of insurance 
• Lobby/Front 
Desk 
• N/A—
already a 
process 
practiced 
and funded 
by the 
clinic 
• At the start of 
every appointment; 
10 mins 
• Front Desk 
Receptionist 
• Placement of 
checklist in chart 
• Checklist • Lobby/Front 
Desk 
• Cost of 
paper and 
printing of 
checklist 
• After determining 
if patient meets 
eligibility criteria, 
checklist is placed 
in chart; 1 min 
• Front Desk 
Receptionist 
• Call back to patient 
room and obtain 
patient’s vital signs 
• Chart with labs and 
SOAP note, 
medical 
• Hallway 
and patient 
exam room 
• N/A—
process of 
the clinic; 
• After receiving 
patient chart; the 
start of the patient 
• Medical 
Assistant 
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 equipment—
stethoscope, BP 
cuff, etc.  
 
 
MA paid 
by 
physician 
care process; 10 
mins 
• Documentation of 
patient’s medication 
and supplements 
• SOAP note and 
checklist 
• Patient 
exam room 
• Cost of 
paper to 
print 
checklist 
• At the beginning 
of patient’s 
appointment; 5 
mins. 
• Medical 
Assistant 
• Comparison of 
patient’s meds with 
Beers Criteria 
• SOAP note, 
checklist, Beers 
Criteria 
• Patient 
exam room 
• Cost of 
paper and 
printing of 
Beers 
Criteria 
pocket 
guide 
• During patient’s 
appointment; 5 
mins 
• Medical 
Assistant 
• Notation/Highlight all 
PIMs that meet Beers 
Criteria 
• Beers Criteria, 
checklist, SOAP 
note with med list 
• Patient 
exam room 
• Cost of 
paper to 
print 
checklist 
and Beers 
Criteria 
• During patient’s 
appointment; 1 
min. 
• Medical 
Assistant 
• Physician enters room; 
assesses patient and 
evaluate treatment plan 
• SOAP note, 
checklist 
• Patient 
exam room 
• Cost for 
checklist 
• During patient’s 
appointment; 20 
mins 
• Physician 
• Physician documents 
treatment plan—to 
continue or alter 
therapy 
• SOAP note, 
checklist 
• Patient 
exam room 
• Cost for 
checklist 
• During patient’s 
appointment; 5 
mins 
• Physician 
• Patient check-out; 
Patient chart given to 
receptionist 
• Patient chart with 
SOAP note and 
checklist inside 
• Hallway/ 
Front Desk 
• N/A • Conclusion of 
patient’s 
• Medical 
Assistant, 
B
E
E
R
S
 C
R
IT
E
R
IA
 IM
P
L
E
M
E
N
T
A
T
IO
N
 
 
 
 
 
 
 
 
           5
2
 
 appointment; 5 
mins 
Front Desk 
Receptionist 
• Checklist removed and 
placed in folder 
• Checklist, folder • Front desk • Cost of 
checklist 
and folder 
• 1 minute • Front Desk 
Receptionist 
• Formulate census of all 
scheduled patients 65 
years and older 
• Appointment book • Hallway 
desk area 
• N/A • Census formulated 
each week; 30 
mins 
• DNP student 
• Collection of 
checklists 
• Folder with 
checklists 
• Front desk 
and 
hallway 
desk area 
• Cost of 
checklists 
• Collection will 
occur every week; 
1 min. 
• DNP student 
• Pulling charts for all 
patients that received 
checklist  
• Checklists to pull 
charts 
• Chart room • N/A • Charts will be 
pulled each week; 
20 mins 
• DNP student 
• Data collection & 
Analysis/Evaluation 
o % of patients’ 
medication lists 
that were 
reviewed based 
on the Beers 
Criteria 
recommendations 
o % of treatment 
plans that are 
changed to a 
safer and 
effective 
• Chart with SOAP 
note, checklist 
o Checklist 
filled out—
MA initialed 
indicating all 
tasks 
(mediation 
documentation 
and review of 
this list with 
Beers Criteria) 
were 
completed  
• Hallway 
desk 
• N/A • Data collection and 
analysis will occur 
every week; 5 hrs 
• DNP student 
B
E
E
R
S
 C
R
IT
E
R
IA
 IM
P
L
E
M
E
N
T
A
T
IO
N
 
 
 
 
 
 
 
 
        5
3
 
 alternative 
treatment option  
o PIMs, type of 
PIM, MCC, 
polypharmacy 
o Physician’s 
documentation 
of his decision 
regarding 
patient’s 
treatment—to 
continue or 
alter 
o If treatment is 
changed, 
alternative 
treatment 
documented 
on either or 
both the 
SOAP note or 
checklist 
• Additional staff 
meetings and 
education sessions 
 
 
 
 
 
 
 
 
 
 
 
• Results of the QI 
measure  
• Office’s 
break room  
• Meal; costs 
of any 
paper to 
print out 
visual 
diagrams 
of the 
results of 
QI measure  
 
 
 
 
 
• 30 min. 
meetings/education 
session during the 
staff’s lunch hour 
o A meeting will 
be scheduled 
at the half-way 
point (Week 
3) of the QI 
project 
o Additional 
meetings may 
be scheduled 
if there are any 
• DNP student; 
all staff 
members 
including 
MD, MA, 
OM, and 
front desk 
receptionist 
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issues, 
questions, or 
concerns 
o The last staff 
meeting will 
be scheduled 
at the 
conclusion of 
this QI 
measure 
(Week 6) 
Note (only if applicable) 
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 Appendix E 
Data Collection Table  
 
D.o.B. Age Race Ethnicity Sex/Gender Diagnoses Insurance Date of Appt. 
Med List 
Reviewed 
with Beers 
Total # of 
Medications
PIMs 
Identified? 
Total # of 
PIMs
Names of 
PIMs
Alternative 
Treatment 
Used?
If alt. 
treatment 
used, 
Meds 
changed 
from…
Meds 
changed 
to…
If not 
changed, 
Rationale?
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BEERS CRITERIA IMPLEMENTATION 
 
57 
 
Appendix F 
Letter of Support 
 
